Unknown NA INTERVENTIONAL 1-arm NCT01147562

Biomarker Discovery and Validation in Lung Cancer (LCS)

Sponsor: Centre Hospitalier du Luxembourg

Updated 7 times since 2017 Last updated: Jan 30, 2019 Started: Oct 14, 2009 Primary completion: Jul 31, 2020 Completion: Oct 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01147562, this NA trial focuses on Lung Cancer and remains ongoing. Sponsored by Centre Hospitalier du Luxembourg, it has been updated 7 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting NA
Mar 2019 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier du Luxembourg
Dr. Guy Berchem
Integrated Biobank of Luxembourg

Data source: Public Research Centre Health, Luxembourg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Luxembourg, Luxembourg